To define characteristics that determine the entry of ketoconazole (KTZ) into Candida albicans cells, we studied the uptake of [3H]KTZ. The cells rapidly and markedly concentrated the drug: 30% of the final 80-fold intracellular concentration was attained in less than 1 min, and >60% was attained in 10 min. Penetration of [3H]KTZ at an extracellular concentration higher than 0.1875 FM (0.1 ,ug/ml) occurred by a simple diffusion mechanism. At lower concentrations, accumulation of the drug was an active, energy-requiring process, dependent at least in part on glycolysis, and pH dependent (optimal pH, 6.6). The active transport system had a high binding affinity (Km = 50 nM) and a high maximum velocity of uptake (V..x = 1.4 ,umol min -10-7 cells). It was not possible to displace intracellular [3H]KTZ with high concentrations of unlabeled KTZ or other antifungal agents. These findings suggest that KTZ is rapidly taken up, highly concentrated, and tightly bound to cellular components of C. albicans.
[3H]KTZ at an extracellular concentration higher than 0.1875 FM (0.1 ,ug/ml) occurred by a simple diffusion mechanism. At lower concentrations, accumulation of the drug was an active, energy-requiring process, dependent at least in part on glycolysis, and pH dependent (optimal pH, 6.6). The active transport system had a high binding affinity (Km = 50 nM) and a high maximum velocity of uptake (V..x = 1.4 ,umol min -10-7 cells). It was not possible to displace intracellular [3H]KTZ with high concentrations of unlabeled KTZ or other antifungal agents. These findings suggest that KTZ is rapidly taken up, highly concentrated, and tightly bound to cellular components of C. albicans.
Ketoconazole (KTZ) (12) is a broad-spectrum antifungal agent which is active against a variety of pathogenic fungi, including Candida albicans and dermatophytes (5) . Several investigators (13, 16) have shown that low concentrations of KTZ inhibit ergosterol synthesis by blocking C-14 demethylation. This fungistatic action can be related to the accumulation of a-methylated intermediates, such as lanosterol, in the fungal membrane. It can also be related to the depletion of ergosterol, which is specifically required for membrane integrity. A recent study (1) showed that high concentrations of KTZ can have a rapid fungicidal action by direct membrane-damaging effect on C. albicans cells.
The high activity of KTZ in vivo against candidosis is in striking contrast to its low activity against C. albicans in vitro in conventional culture media (4) .
The ability of antifungal agents to enter yeast cells may be an important factor affecting pathogen susceptibility and the outcome of therapy.
Because little is known about the factors which mediate the entry of KTZ into C. albicans cells and about the permeation process, we examined the in vitro uptake of this antifungal agent.
MATERIALS AND METHODS
Organism and growth conditions. C. albicans IP 740, supplied by the Collection of the Institut Pasteur, Paris, France, was maintained on Casitone (Difco Laboratories, Detroit, Mich.) liquid medium at 37°C (5 concentrations ranging from 9.38 nM (5 ng/ml) to 0.6 ,uM (0.32 ,ug/ml).
The cell-KTZ mixtures were incubated at 37°C; at 10-min intervals, 1-ml samples (containing 107 cells) of the incubation suspensions were removed, and [3H]KTZ uptake was measured as follows. The samples were filtered on GF/C filters (Whatman, Inc., Clifton, N.J.), washed with 2 ml of a solution containing 1 mg of unlabeled drug per ml to remove the unbound labeled compound, and washed with 5 ml of sterile distilled water. Filters were assayed for radioactivity by liquid scintillation counting (Instagel scintillant; Packard Instrument Co., Inc., Rockville, Md.).
The intracellular volume was approximated by adding 3H20 (C.E.A., Saclay, France) to the C. albicans cell suspensions, allowing the suspensions to reach equilibrium, and then directly counting the nonincorporated radioactivity in the supernatant. Based on the values obtained by this procedure, cell-associated KTZ concentrations were calculated and expressed as the ratio of the cellular concentration to the extracellular concentration. All of the intracellular volume was assumed to be available for uptake: this is not entirely accurate because, in most biological systems, the intracellular fluids account for approximately 80% of the cell volume.
Characterization of KTZ uptake. Further studies were done to elucidate the mechanism of [3H]KTZ uptake by C. albicans. We determined whether cell viability was required for uptake, using cells killed by exposure to 60°C for 1 h and then suspended in fresh buffer. The effect of temperature on drug uptake was also evaluated at the [3H]KTZ concentrations of 0.1875 and 0.938 ,uM (0.5 ,g/ml).
The following metabolic inhibitors were used at concentrations of 4, 10, or 20 mM: sodium azide (Sigma Chemical Co., St. Louis, Mo.) and sodium fluoride and 2,4-dinitrophenol (Prolabo, Paris, France Similar experiments were done with antifungal agents other than KTZ, whose concentrations were as follows: clotrimazole (Bayer, Leverkusen, Federal Republic of Germany), 29.00 ,uM (10 ,ug/ml); miconazole (Janssen),.20.88 ,uM (10 ,ug/ml); econazole (Cilag Chimie, Schlassausen, Switzerland), 22.55 ,uM (10 ,ug/ml); itraconazole (Janssen), 14.13 ,uM (10 ,ug/ml); amphotericin B (Squibb,' New Brunswick, N.J.), 10.82 ,M (10 ,ug/ml); and flucytosine (Roche Diagnostics, Div. Hoffman-La Roche Inc., Nutley, N.J.), 77.46',M (10 ,ug/ml).
RESULTS
KTZ uptake by C. albicans. The cells were viable throughout the experiment as determined by their ability to grow on culture medium. The pattern of uptake of [3H]KTZ by cells at 37°C is shown in Fig. 1 The markedly decreased uptake at 4°C, at both [31J]KTZ concentrations, may reflect decreased drug solubility in a cell membrane altered by low temperature.
We used various metabolic inhibitors at different concentrations to further elucidate the active transport system involved in [3H]KTZ uptake (Fig. 3) : sodium azide (NaN3), an inhibitor of oxidized cytochrome oxidase, and sodium fluoride (NaF), an inhibitor of glycolysis, both'used at 20 mM, significantly reduced [3H]KTZ uptake (bottom panel). But NaN3 at this concentration decreased cell viability. NaN3 at 10 mM, at which' cell viability is not affected, had no effect on drug uptake. 2 oxidative phosphorylation, had no effect at either 4 or 10 mM.
NaF at 20 mM did not inhibit [3HIKTZ uptake when the drug was used at an extracellular concentration of 0.938 ,uM (Fig. 3, top panel) .
Effect of pH. The uptake of [3H]KTZ was pH dependent; intracellular concentration was maximal at pH 6.6 (Fig. 4) .
Kinetic analysis of KTZ uptake. A kinetic analysis of [3H]KTZ entry into C. albicans cells during the first 2 min of exposure to the antifungal agent is shown in Fig. 5 . Effect of unlabeled drugs.
[3H]KTZ seems tightly bound to the cellular component. Unlabeled KTZ added at concentrations 100-to 500-fold greater than that of [3H]KTZ did not result in significant efflux of the labeled drug (Fig. 6) .
Efflux experiments with other antifungal drugs revealed that the [3H]KTZ remained bound to the C. albicans cells (Fig. 7) (2, 10) . In vitro combinations of amphotericin B with various antifungal imidazoles have given conflicting results (3, 6, 8, 11) , but in vivo the association of amphotericin B-KTZ was found to be somewhat superior to either drug alone (9) .
Because KTZ basically acts in the same manner as other imidazole antifungal agents, its greater actiyity against yeasts than against other fungi, e.g., Aspergillus fumigatus, could be attributed to the distinct properties of the molecule. These could include more rapid influx across the cell membrane or greater intracellular binding.
Moreover, the relationship between the two modes of action of KTZ and the two mechanisms of drug uptake deserves further attention.
